Skip to content
Back to LYCA

Lycia Therapeutics, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
12
Purchases
12
Sales
0
Purchase value
$38.52M
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Koh Bong Y10% owner
Shah Nimish P10% owner
Venrock Healthcare Capital Partners EG, L.P.10% owner
Venrock Healthcare Capital Partners III, L.P.10% owner
Venrock Healthcare Capital Partners XP, L.P.10% owner
VHCP Co-Investment Holdings III, LLC10% owner
VHCP Management EG, LLC10% owner
VHCP Management III, LLC10% owner
VHCP Management XP, LLC10% owner
4
Filed Nov 4, 2026Period of report Nov 2, 20260001231919-26-001536
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 2, 2026
Common StockF1F2F3F4F5F68,305$26.95$223.82K6,858,542IndirectBy Funds
Filing footnotes · 6
  1. F1Consists of (i) 3,775 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 378 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 4,152 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
  2. F2The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.60 to $27.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  3. F3Consists of (i) 1,773,271 shares held by VHCP3; (ii) 177,470 shares held by VHCP Co-3; (iii) 4,256,011 shares held by VHCP EG; and (iv) 651,790 shares held by Venrock Healthcare Capital Partners XP, L.P. ("VHCP XP").
  4. F4VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own the shares held by VHCP3 and VHCP Co-3. Bong Koh and Nimish Shah are the voting members of VHCPM3 and may be deemed to beneficially own these shares. Each of VHCPM3 and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
  5. F5VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCP EG and may be deemed to beneficially own the shares held by VHCP EG. Bong Koh and Nimish Shah are the voting members of VHCPMEG and may be deemed to beneficially own these shares. Each of VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
  6. F6VHCP Management XP, LLC ("VHCPMXP") is the general partner of VHCP XP and may be deemed to beneficially own the shares held by VHCP XP. Bong Koh and Nimish Shah are the voting members of VHCPMXP and may be deemed to beneficially own these shares. Each of VHCPMXP and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
Open on SEC EDGAR
Koh Bong Y10% owner
Shah Nimish P10% owner
Venrock Healthcare Capital Partners EG, L.P.10% owner
Venrock Healthcare Capital Partners III, L.P.10% owner
Venrock Healthcare Capital Partners XP, L.P.10% owner
VHCP Co-Investment Holdings III, LLC10% owner
VHCP Management EG, LLC10% owner
VHCP Management III, LLC10% owner
VHCP Management XP, LLC10% owner
4
Filed Oct 30, 2026Period of report Oct 28, 20260001231919-26-001519
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 30, 2026
Common StockF13F14F15F4F5F68,804$26.27$231.28K6,850,037IndirectBy Funds
PurchaseOct 30, 2026
Common StockF16F17F18F4F5F6200$26.86$5.37K6,850,237IndirectBy Funds
PurchaseOct 29, 2026
Common StockF10F11F12F4F5F61,000$26.33$26.33K6,841,233IndirectBy Funds
PurchaseOct 28, 2026
Common StockF1F2F3F4F5F610,570$25.23$266.68K6,835,803IndirectBy Funds
PurchaseOct 28, 2026
Common StockF7F8F9F4F5F64,430$25.97$115.05K6,840,233IndirectBy Funds
Filing footnotes · 18
  1. F1Consists of (i) 4,804 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 481 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 5,285 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
  2. F10Consists of (i) 455 shares held by VHCP3; (ii) 45 shares held by VHCP Co-3; and (iii) 500 shares held by VHCP EG.
  3. F11The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.26 to $26.40 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  4. F12Consists of (i) 1,765,404 shares held by VHCP3; (ii) 176,682 shares held by VHCP Co-3; (iii) 4,247,357 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
  5. F13Consists of (i) 4,001 shares held by VHCP3; (ii) 401 shares held by VHCP Co-3; and (iii) 4,402 shares held by VHCP EG.
  6. F14The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $25.70 to $26.64 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  7. F15Consists of (i) 1,769,405 shares held by VHCP3; (ii) 177,083 shares held by VHCP Co-3; (iii) 4,251,759 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
  8. F16Consists of (i) 91 shares held by VHCP3; (ii) 9 shares held by VHCP Co-3; and (iii) 100 shares held by VHCP EG.
  9. F17The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.84 to $26.87 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  10. F18Consists of (i) 1,769,496 shares held by VHCP3; (ii) 177,092 shares held by VHCP Co-3; (iii) 4,251,859 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
  11. F2The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $24.77 to $25.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  12. F3Consists of (i) 1,762,936 shares held by VHCP3; (ii) 176,435 shares held by VHCP Co-3; (iii) 4,244,642 shares held by VHCP EG; and (iv) 651,790 shares held by Venrock Healthcare Capital Partners XP, L.P. ("VHCP XP").
  13. F4VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own the shares held by VHCP3 and VHCP Co-3. Bong Koh and Nimish Shah are the voting members of VHCPM3 and may be deemed to beneficially own these shares. Each of VHCPM3 and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
  14. F5VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCP EG and may be deemed to beneficially own the shares held by VHCP EG. Bong Koh and Nimish Shah are the voting members of VHCPMEG and may be deemed to beneficially own these shares. Each of VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
  15. F6VHCP Management XP, LLC ("VHCPMXP") is the general partner of VHCP XP and may be deemed to beneficially own the shares held by VHCP XP. Bong Koh and Nimish Shah are the voting members of VHCPMXP and may be deemed to beneficially own these shares. Each of VHCPMXP and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
  16. F7Consists of (i) 2,013 shares held by VHCP3; (ii) 202 shares held by VHCP Co-3; and (iii) 2,215 shares held by VHCP EG.
  17. F8The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $25.88 to $26.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  18. F9Consists of (i) 1,764,949 shares held by VHCP3; (ii) 176,637 shares held by VHCP Co-3; (iii) 4,246,857 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
Open on SEC EDGAR
Koh Bong Y10% owner
Shah Nimish P10% owner
Venrock Healthcare Capital Partners EG, L.P.10% owner
Venrock Healthcare Capital Partners III, L.P.10% owner
Venrock Healthcare Capital Partners XP, L.P.10% owner
VHCP Co-Investment Holdings III, LLC10% owner
VHCP Management EG, LLC10% owner
VHCP Management III, LLC10% owner
VHCP Management XP, LLC10% owner
4
Filed Oct 27, 2026Period of report Oct 23, 20260001231919-26-001503
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 27, 2026
Common StockF17F18F19F3F4F118,729$25.84$225.56K6,794,166IndirectBy Funds
PurchaseOct 27, 2026
Common StockF20F21F22F3F4F1131,067$26.84$833.84K6,825,233IndirectBy Funds
PurchaseOct 26, 2026
Common StockF12F13F3F4F111,944,444$18.00$35.00M6,777,176IndirectBy Funds
PurchaseOct 26, 2026
Common StockF14F15F16F3F4F118,261$26.97$222.80K6,785,437IndirectBy Funds
PurchaseOct 23, 2026
Common StockF1F2F3F424,560$25.68$630.70K24,560IndirectBy Funds
PurchaseOct 23, 2026
Common StockF5F6F7F3F428,379$26.11$740.98K52,939IndirectBy Funds
Filing footnotes · 26
  1. F1Consists of (i) 11,163 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 1,118 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 12,279 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
  2. F10Consists of (i) 852,540 shares held by VHCP3; (ii) 85,295 shares held by VHCP Co-3; (iii) 3,243,107 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
  3. F11VHCP Management XP, LLC ("VHCPMXP") is the general partner of VHCP XP and may be deemed to beneficially own the shares held by VHCP XP. Bong Koh and Nimish Shah are the voting members of VHCPMXP and may be deemed to beneficially own these shares. Each of VHCPMXP and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
  4. F12Consists of (i) 883,750 shares held by VHCP3; (ii) 88,472 shares held by VHCP Co-3; and (iii) 972,222 shares held by VHCP EG.
  5. F13Consists of (i) 1,736,290 shares held by VHCP3; (ii) 173,767 shares held by VHCP Co-3; (iii) 4,215,329 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
  6. F14Consists of (i) 3,755 shares held by VHCP3; (ii) 376 shares held by VHCP Co-3; and (iii) 4,130 shares held by VHCP EG.
  7. F15The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.82 to $27.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  8. F16Consists of (i) 1,740,045 shares held by VHCP3; (ii) 174,143 shares held by VHCP Co-3; (iii) 4,219,459 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
  9. F17Consists of (i) 3,967 shares held by VHCP3; (ii) 397 shares held by VHCP Co-3; and (iii) 4,365 shares held by VHCP EG.
  10. F18The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $25.28 to $26.27 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  11. F19Consists of (i) 1,744,012 shares held by VHCP3; (ii) 174,540 shares held by VHCP Co-3; (iii) 4,223,824 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
  12. F2The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $25.00 to $25.99 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  13. F20Consists of (i) 14,120 shares held by VHCP3; (ii) 1,414 shares held by VHCP Co-3; and (iii) 15,533 shares held by VHCP EG.
  14. F21The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.28 to $27.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  15. F22Consists of (i) 1,758,132 shares held by VHCP3; (ii) 175,954 shares held by VHCP Co-3; (iii) 4,239,357 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
  16. F23Consists of (i) 3,735,368 shares held by VHCP3; (ii) 373,708 shares held by VHCP Co-3; and (iii) 13,033,502 shares held by VHCP EG.
  17. F24Consists of (i) 828,479 shares held by VHCP3; (ii) 82,885 shares held by VHCP Co-3; and (iii) 2,890,744 shares held by VHCP EG.
  18. F25Consists of (i) 1,469,363 shares held by VHCP EG and (ii) 2,938,728 shares held by VHCP XP.
  19. F26Consists of (i) 325,895 shares held by VHCP EG and (ii) 651,790 shares held by VHCP XP.
  20. F3VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own the shares held by VHCP3 and VHCP Co-3. Bong Koh and Nimish Shah are the voting members of VHCPM3 and may be deemed to beneficially own these shares. Each of VHCPM3 and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
  21. F4VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCP EG and may be deemed to beneficially own the shares held by VHCP EG. Bong Koh and Nimish Shah are the voting members of VHCPMEG and may be deemed to beneficially own these shares. Each of VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
  22. F5Consists of (i) 12,898 shares held by VHCP3; (ii) 1,292 shares held by VHCP Co-3; and (iii) 14,189 shares held by VHCP EG.
  23. F6The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.00 to $26.25 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  24. F7Consists of (i) 24,061 shares held by VHCP3; (ii) 2,410 shares held by VHCP Co-3; and (iii) 26,468 shares held by VHCP EG.
  25. F8Consists of (i) 828,479 shares held by VHCP3; (ii) 82,885 shares held by VHCP Co-3; (iii) 3,216,639 shares held by VHCP EG; and (iv) 651,790 shares held by Venrock Healthcare Capital Partners XP, L.P. ("VHCP XP").
  26. F9Each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-0.221793422 basis upon the closing of the Issuer's initial public offering on October 26, 2026 without payment of consideration. The Series C Preferred Stock and Series D Preferred Stock had no expiration date.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.